M1222 – Glaucoma plan of care not documented, reason not otherwise specified

Long description

Glaucoma plan of care not documented, reason not otherwise specified

Short description

Glaucoma pln of care not doc

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1214 – Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed
• M1215 – Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)
• M1216 – No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter
• M1217 – Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)
• M1218 – Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
• M1219 – Anaphylaxis due to the vaccine on or before the date of the encounter
• M1220 – Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy
• M1221 – Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
• M1223 – Glaucoma plan of care documented
• M1224 – Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
• M1225 – Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
• M1226 – Iop measurement not documented, reason not otherwise specified
• M1227 – Evidence-based therapy was prescribed
• M1228 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
• M1229 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
• M1230 – Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given